Dicarboxylic aminoaciduria

Revision as of 16:54, 24 November 2015 by Carlos Lopez (talk | contribs) (Created page with "{{Infobox disease | Name = Dicarboxylic aminoaciduria | Image = | Caption = | DiseasesDB = 14901 | ICD10 = E72.0 | ICD9...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Dicarboxylic aminoaciduria
Classification and external resources
ICD-10 E72.0
OMIM 222730
DiseasesDB 14901
MeSH C536171
Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
Identifiers
Symbols SLC1A1 ; EAAC1; EAAT3
External IDs Template:OMIM5 Template:MGI HomoloGene20881 ChEMBL: 2721 GeneCards: SLC1A1 Gene
RNA expression pattern
File:PBB GE SLC1A1 213664 at tn.png
File:PBB GE SLC1A1 206396 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 6505 20510
Ensembl ENSG00000106688 ENSMUSG00000024935
UniProt P43005 P51906
RefSeq (mRNA) NM_004170 NM_009199
RefSeq (protein) NP_004161 NP_033225
Location (UCSC) Chr 9:
4.49 – 4.59 Mb
Chr 19:
28.84 – 28.91 Mb
PubMed search [1] [2]

Dicarboxylic aminoaciduria is a rare form of aminoaciduria (1:35 000 births[1]) which is an autosomal recessive disorder of urinary glutamate and aspartate due to genetic errors related to transport of these amino acids.[2] Mutations resulting in a lack of expression of the SLC1A1 gene, a member of the solute carrier family, are found to cause development of dicarboxylic aminoaciduria in humans. SLC1A1 encodes for EAAT3 which is found in the neurons, intestine, kidney, lung, and heart.[2][3] EAAT3 is part of a family of high affinity glutamate transporters which transport both glutamate and aspartate across the plasma membrane.

Symptoms

Dicarboxylic aminoaciduria involves excretion of urinary glutamate and aspartate, resulting from the incomplete reabsorption of anionic amino acids from the glomerular filtrate in the kidney.[2] This has an impact on a diseased individual's amino acid pool, as they will have to spend additional resources to replenish the amino acids which would have otherwise been present. Additionally, glutamate transporters are responsible for the synaptic release of the glutamate (neurotransmitter) within the interneuronal synaptic cleft. This hindrance of functionality in individuals with dicarboxylic aminoaciduria may be related to growth retardation, intellectual disability, and a tendency toward fasting hypoglycemia and ketoacidosis .[2][4] Dicarboxylic aminoaciduria is diagnosed by finding the increased presence of glutamate and aspartate in the urine.[2]

Transport

File:Glutamatergic Synapse.png
Basic transport of glutamate in the synapse as well as the neuroglia.

Glutamate transporters are proficient at pumping glutamate into cells due to their ability to couple with inorganic ions.[3] Transport of glutamate into the cell requires the coupling of three sodium ions as well as a proton, whereas transport out of the cell requires a single potassium ion.[3] This transport results in two positive charges being displaced across the membrane per cycle.[3] Moreover, this process is dependent on a pH gradient, due to glutamate needing to be protenated prior to transport.[3]

Mutations

Dicarboxylic aminoaciduria is the result of a point mutation of tryptophan to arginine at position 445 and a deletion mutation of isoleucine at position 395.[2] EAAT3 is found in location 9p24, it is primarily expressed in the brain and kidneys.[5]

Metabolism

In the gastrointestinal tract, protein digestion and absorption are key to establishing and maintaining amino acid pools. In the case of dicarboxylic aminoaciduria, where glutamate and aspartate transport are impaired, the alanine, aspartate and glutamate metabolism are impacted. Enterocytes in the intestines break up peptides into residual amino acids where they would normally use charge-specific amino acid transporters to get across the epithelial cells. In dicarboxylic aminoaciduria, the anionic amino acid transporter, EAAT3, cannot bring glutamate and aspartate across epithelial cells, leading to them being excreted via the urine.

Examples

Below is an example of how glutamate is used to synthesize alanine via alanine transaminase.

Glutamate + pyruvate Template:Unicode α-ketoglutarate + Alanine
Alanine transaminase

Another example is the conversion of aspartate to glutamate via the enzyme aspartate transaminase.

Aspartate + α-ketoglutarate Template:Unicode Oxaloacetate + Glutamate
File:Aspartate aminotransferase reaction.png
Aspartate transaminase

.

References

  1. Camargo SM, Bockenhauer D, Kleta R (April 2008). "Aminoacidurias: Clinical and molecular aspects". Kidney Int. 73 (8): 918–25. doi:10.1038/sj.ki.5002790. PMID 18200002.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Bröer S, Rasko JE (January 2011). "Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria". J. Clin. Invest. 121 (1): 446–53. doi:10.1172/JCI44474. PMC 3007158. PMID 21123949.
  3. 3.0 3.1 3.2 3.3 3.4 Hediger MA (October 1999). "Glutamate transporters in kidney and brain". Am. J. Physiol. 277 (4 Pt 2): F487–92. PMID 10516270.
  4. Bröer S. (January 2008). "Amino acid transport across mammalian intestinal and renal epithelia". Physiol Rev. 88 (1): 249–86. doi:10.1152/physrev.00018.2006. PMID 18195088.
  5. Smith CP, Weremowicz S, Kanai Y, Stelzner M, Morton CC, Hediger MA. (March 1994). "Assignment of the gene coding for the human high-affinity glutamate transporter EAAC1 to 9p24: potential role in dicarboxylic aminoaciduria and neurodegenerative disorders". Genomics. 277 (2): 335–336. doi:10.1006/geno.1994.1183. PMID 8020993.